By Deron Hamel A 2,000-per-cent price hike on a medication to treat infantile spasms is “predatory behaviour” on the part of Questcor Pharmaceuticals, and drug companies could hike prices on other seizure medications if policies aren’t put into place, says pediatric neurologist Dr. Carter Snead. Infantile spasms – also called West syndrome – is a…
By Deron Hamel It wasn’t long after Sarah Hysenaj had her first seizure that she became an epilepsy awareness advocate. Sarah was 11 years old and on a school field trip when she had her first seizure in front of her classmates. Fortunately for Sarah, her teacher knew exactly what was happening and what to…
By Deron Hamel The Supreme Court of Canada’s landmark decision to legalize all forms of consumption of medicinal marijuana means Mandy McKnight no longer has to break the law in order to stop her young son’s seizures. Mandy’s seven-year-old son, Liam, has Dravet syndrome, a severe form of epilepsy with frequent, prolonged, drug-resistant seizures. He…
By Deron Hamel Results from an early phase clinical trial suggest that cannabidiol (CBD) may be an effective treatment for stemming the number of seizures for people living with severe, drug-resistant forms of epilepsy, however, randomized controlled trials are needed before conclusions can be drawn on the chemical compound’s effectiveness, says Dr. Elizabeth Donner. While…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
